These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26857204)

  • 1. A membranous nephropathy case: Is it related to sulfasalazine?
    Bagdatoglu O; Maras Y; Yayar O; Eser B
    Nefrologia; 2016; 36(3):330-1. PubMed ID: 26857204
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis].
    Kawano M; Nomura H; Iwainaka Y; Nakashima A; Koni I; Tofuku Y; Takeda R
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of membranous nephropathy and systemic lupus erythematosus associated with abatacept in rheumatoid arthritis.
    Asami Y; Ishiguro H; Ueda A; Nakajima H
    Clin Exp Rheumatol; 2016; 34(6):1122. PubMed ID: 27462998
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis.
    Obayashi M; Uzu T; Harada T; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Dec; 7(4):275-8. PubMed ID: 14712356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membranous nephropathy associated with the relatively selective cyclooxygenase-2 inhibitor, etodolac, in a patient with early rheumatoid arthritis.
    Sugimoto T; Aoyama M; Kikuchi K; Sakaguchi M; Deji N; Uzu T; Nishio Y; Kashiwagi A
    Intern Med; 2007; 46(13):1055-8. PubMed ID: 17603251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis.
    Narayan N; Rigby S; Carlucci F
    Clin Rheumatol; 2017 Feb; 36(2):477-479. PubMed ID: 27778097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Membranous nephropathy secondary to rheumatoid arthritis occurring during anti-TNFalpha therapy and responsive to second-line treatment with rituximab].
    Giordano A; Cencioni L; Salvo DP; Berrettini M
    G Ital Nefrol; 2011; 28(2):214-8. PubMed ID: 21488037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranous nephropathy in rheumatoid arthritis: a case report.
    Maruotti N; Corrado A; Gaudio A; Cantatore FP
    Clin Exp Rheumatol; 2009; 27(5):840-2. PubMed ID: 19917171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranous nephropathy with crescents in rheumatoid arthritis: a case report.
    Dohi K; Shiiki H; Kawano T; Kanauchi M; Ishikawa H; Watanabe T
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):523-7. PubMed ID: 1895551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Membranous glomerulonephritis probably related to bucillamine therapy in two patients with rheumatoid arthritis].
    Baba N; Nomura T; Sakemi T; Uchida M; Watanabe T
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):629-34. PubMed ID: 1920943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and treatment of bucillamine-induced nephropathy.
    Hoshino J; Ubara Y; Hara S; Suwabe T; Sawa N; Tagami T; Katori H; Takemoto F; Hara S; Takaichi K
    Nephron Clin Pract; 2006; 104(1):c15-9. PubMed ID: 16685139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestasis and fatal agranulocytosis complicating sulfasalazine therapy: case report and review of the literature.
    Mitrane MP; Singh A; Seibold JR
    J Rheumatol; 1986 Oct; 13(5):969-72. PubMed ID: 2880997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rheumatoid arthritis: Pathogenesis, pathophysiology, and therapy].
    Tamura N; Hashimoto H
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():450-3. PubMed ID: 16523932
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinicopathological study of membranous glomerulonephritis in patients with rheumatoid arthritis].
    Shimokama T; Baba N; Shouno Y; Watanabe T; Sakemi T; Harada A
    Nihon Jinzo Gakkai Shi; 1992 Mar; 34(3):301-7. PubMed ID: 1630032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membranous nephropathy associated with fluconazole treatment.
    Shin GT; Yim H; Park J; Kim H
    Am J Kidney Dis; 2007 Feb; 49(2):318-22. PubMed ID: 17261435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sulfasalazine-induced megaloblastic anemia in rheumatoid arthritis].
    López R; Cuquet J; Fitó R; Pujol R
    Med Clin (Barc); 1988 Oct; 91(14):559. PubMed ID: 2905757
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfasalazine induced lupus in rheumatoid arthritis.
    Caulier M; Dromer C; Andrieu V; Le Guennec P; Fournie B
    J Rheumatol; 1994 Apr; 21(4):750-1. PubMed ID: 7913504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Megaloblastic anemia caused by sulfasalazine in rheumatoid arthritis or ankylosing spondylitis?].
    Med Clin (Barc); 1989 Jun; 93(2):76-7. PubMed ID: 2569051
    [No Abstract]   [Full Text] [Related]  

  • 19. [Agranulocytosis in rheumatoid polyarthritis treated with sulfasalazine].
    Pointud P; Cauhape P; Favreau A
    Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):573. PubMed ID: 2569228
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal agranulocytosis in sulfasalazine treated rheumatoid arthritis.
    Guillemin F; Aussedat R; Guerci A; Lederlin P; Trechot P; Pourel J
    J Rheumatol; 1989 Aug; 16(8):1166-7. PubMed ID: 2573730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.